Merdad Parsey - Mar 10, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Mar 10, 2024
Transactions value $
-$360,801
Form type
4
Date filed
3/11/2024, 09:14 PM
Previous filing
Feb 29, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.46K +3.73% 96.2K Mar 10, 2024 Direct F1
transaction GILD Common Stock Options Exercise +6.95K +7.22% 103K Mar 10, 2024 Direct F1
transaction GILD Common Stock Tax liability -$361K -4.8K -4.66% $75.12 98.3K Mar 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.46K -8.43% 37.5K Mar 10, 2024 Common Stock 3.46K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -6.95K -18.51% 30.6K Mar 10, 2024 Common Stock 6.95K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +89.7K $0.00 89.7K Mar 10, 2024 Common Stock 89.7K $75.12 Direct F4
transaction GILD Restricted Stock Unit Award +17.6K +57.7% 48.2K Mar 10, 2024 Common Stock 17.6K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.